← FDA Drug Approvals (Drugs@FDA)

ABSTRAL

NDA · New Drug Application · Sponsor: SENTYNL THERAPS INC · Approved 2011-01-07

Drug application

FDA Application #

NDA022510

Application type

New Drug Application

Brand name

ABSTRAL

Generic name

Fentanyl Citrate

Active ingredients

FENTANYL CITRATE

Dosage form

TABLET

Route

SUBLINGUAL

Marketing status

Discontinued

Sponsor

SENTYNL THERAPS INC

First approval

2011-01-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown